Scholten R J, Poolman J T, Valkenburg H A, Bijlmer H A, Dankert J, Caugant D A
Institute for Research in Extramural Medicine, Vrije Universiteit, Amsterdam, Netherlands.
J Infect Dis. 1994 Mar;169(3):673-6. doi: 10.1093/infdis/169.3.673.
To characterize the phenotypic and genotypic changes that occurred in a new clone lineage of Neisseria meningitidis (lineage III) in the Netherlands, the electrophoretic type (ET) was determined for 79 serogroup B isolates of serotype 4 or subtype P1.4 (or both) obtained between 1958 and 1990 from patients with systemic meningococcal disease. Thirty-five previously described isolates were also included. After its appearance in 1980, lineage III started homogeneously with regard to both genotype (ET-24) and phenotype (B:4:P1.4). After 1984, other clones appeared in the lineage, and the various clones acquired other serotypes (serotypes 14 and 15) and subtypes (P1.2, P1.7, and P1.12), indicating frequent exchange of genetic material between clones. These results indicate that basing a serogroup B vaccine on outer membrane components from a single strain is not a valid strategy for the prevention of meningococcal disease.
为了描述荷兰出现的新型脑膜炎奈瑟菌克隆谱系(谱系III)中发生的表型和基因型变化,我们对1958年至1990年间从患有全身性脑膜炎球菌病的患者中分离出的79株血清群B、血清型4或亚型P1.4(或两者兼具)的菌株测定了电泳型(ET)。还纳入了35株先前描述过的分离株。1980年谱系III出现后,在基因型(ET-24)和表型(B:4:P1.4)方面均开始呈现同质化。1984年后,谱系中出现了其他克隆,并且各种克隆获得了其他血清型(血清型14和15)和亚型(P1.2、P1.7和P1.12),这表明克隆之间频繁发生遗传物质交换。这些结果表明,基于单一菌株外膜成分的血清群B疫苗并非预防脑膜炎球菌病的有效策略。